Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Valeant Pharmaceuticals Intl (NYSE: VRX)


Last Updated: Jan-20-2017 20:05:25

Recent Market News

Today's Valeant Pharmaceuticals Stock Update

For your one quick stop for Valeant Pharmaceuticals stock daily numbers today (January 21, 2017), look no further. We've put the most important VRX data here.Valeant Pharmaceuticals shares went down 1.14% or $0.17 from the day before, taking the Valeant Pharmaceuticals closing price to $14.73.Looking at the 52-week highs and lows for VRX is a good way to make sense of the current price, so let's do that now...VRX is now trading lower than it was one-year ago, with the stock price lower by 83.51% since then.

BREAKING: How a 26(f) Program Can Save Your Retirement

The Valeant Pharmaceuticals stock price 52-week high is $101.40. That was hit on 2/02/2016. The VRX stock 52-week low is $13.00, reached on 12/15/2016.Another point to note - VRX trading volume yesterday was 9,508,199. That's more than Valeant Pharmaceuticals stock's average daily trading volume of 9,367,967.Valeant Pharmaceuticals's market cap is 5,119,264,000. That gives Valeant Pharmaceuticals a mid-size market cap, because it's been 2 billion and 10 billion. As of the beginning of April, Apple has the biggest market cap of all publicly traded companies.

TRENDING: The Best Stocks to Buy Now

The current P/E (price/earnings) ratio of Valeant Pharmaceuticals stock is 2.25. That's lower than the March 2016 S&P 500 P/E ratio of about 23. To really gauge if this stock's P/E is high or low, you should compare VRX to other companies in the same industry.The current EPS (earnings per share) of VRX is -6.43.Beta - how closely the stock trades with the overall market, with a beta of 1 meaning it trades in step with the broader index -- for Valeant Pharmaceuticals is -0.13.Valeant Pharmaceuticals stock does not pay a dividend right now. Most stocks considered "dividend stocks" have a yield of 2% or more.Every day we publish Valeant Pharmaceuticals stock news and coverage on a handful of other key stocks we're watching now so you can maximize profits. To get new info and stock news on VRX and other companies you are interested in, sign up for Money Morning - it's free.

UP NEXT: These Are the Top 5 Marijuana Stocks to Watch in 2017 - Don't Miss This Sector's Staggering Profit Potential

Click here to read more stories

Premium Research

Valeant Pharmaceuticals Intl (NYSE: VRX) Profile

Volume9,367,900
Open$14.84
Prior Close$14.9
Market Cap$5.12 B
PE Ratio2.21
Beta-0.13
Valeant Pharmaceuticals International Inc. is a pharmaceutical company that develops manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology dermatology and branded generics. The Company produces medicines that meet the special health problems of patients. Valeant's development pipeline strategy comprises both new compounds as well as product life cycle management. Its early and late-stage drug candidates have unique formulations and mechanisms of action including retigabine for the treatment of epilepsy and pain taribavirin of the treatment of chronic hepatitis C and several dermatology candidates for the treatment of rosacea acne and dermatological fungus. Valeant Pharmaceuticals International Inc. is headquartered in Mississauga Canada.
SymbolCompanyMarket cap
SHPGShire Plc Ads$49.45 B
TKPYYTakeda Pharma$32.53 B
ALPMYAstellas Pharma Inc$28.81 B
ZTSZoetis Inc Class A Common Stoc$26.42 B
GRFSGrifols S.A.$11.57 B
TSROTesaro Inc$8.01 B
JAZZJazz Pharma Plc$7.45 B
UTHRUnited Therapeutic$6.51 B
IONSIonis Pharmaceutical$5.66 B
ARIAAriad Pharm Inc$4.61 B

VRX Earnings

1st Quarter Earnings$1.55 (2016-11-08)
2nd Quarter Earnings$1.4 (2016-08-09)
3rd Quarter Earnings$1.27 (2016-06-07)
4th Quarter Earnings$2.5 (2016-03-15)
PE Ratio2.21
EPS Growth-3.17%
Recent Earnings$1.55
Annual EPS$6.73
Market Capitalization$5.12 B
Insider Shareholder %0.1637%
Annual Revenue$10.01 B
Number of Shares Outstanding347,540 Shares
Institutional Shareholder %64.94%
Annual Net Income$0B
TTM Net Profit Margin$436.04
One Year Return-83.37%
Three Year Return-89.31%
Five Year Return-70.85%
Five Year Revenue Growth0%
Five Year Earnings Growth0%
Five Year Dividend Growth0%
Last Quarter EPS$1.55
Annual EPS$6.73
Annual Dividend$0
Annual Dividend Yield0%
Change in EPS YTD-3.17%
PE Ratio2.21
Recent Earnings$1.55
Dividends per Share$1
Stock Split Ratio2-1
beta-0.13

VRX Key Stats

Last Price$14.73
Net Change$-0.17 (-1.14%)
Bid$0
Ask Price$0
Open Price$14.84
Previous Close Price$14.9
High Price$15.05
Low Price$14.71
Number of Trades23,994
Volume9,367,900
Fifty Two Week High$101.4 (2016-02-02)
Fifty Two Week Low$13 (2016-12-15)
Average Daily Volume15,783,323
Share Outstanding347,540 Shares
Total Dividend Payout$0/yr
Dividend Yield0%